Cargando…
Abiraterone acetate and prednisone in metastatic castration-resistant prostate cancer: a real-world retrospective study in China
BACKGROUND: This research work was aimed at evaluating the incidence and risk factors of adverse events (AEs) occurring in patients treated with abiraterone acetate (AA) and prednisone (PDN) outside clinical trials. These associations were assessed regarding the survival outcomes. METHODS: The study...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213513/ https://www.ncbi.nlm.nih.gov/pubmed/37251681 http://dx.doi.org/10.3389/fendo.2023.1158949 |